107 related articles for article (PubMed ID: 19102687)
1. Prevalence of nevirapine-associated resistance mutations after single dose prophylactic treatment among antenatal clinic attendees in north rift Kenya.
Kiptoo M; Ichimura H; Wembe RL; Ng'Ang'a Z; Mueke J; Kinyua J; Lagat N; Okoth F; Songok EM
AIDS Res Hum Retroviruses; 2008 Dec; 24(12):1555-9. PubMed ID: 19102687
[TBL] [Abstract][Full Text] [Related]
2. Emergence of NNRTI drug resistance mutations after single-dose nevirapine exposure in HIV type 1 subtype C-infected infants in India.
Kurle SN; Gangakhedkar RR; Sen S; Hayatnagarkar SS; Tripathy SP; Paranjape RS
AIDS Res Hum Retroviruses; 2007 May; 23(5):682-5. PubMed ID: 17530993
[TBL] [Abstract][Full Text] [Related]
3. Antiretroviral resistance patterns and HIV-1 subtype in mother-infant pairs after the administration of combination short-course zidovudine plus single-dose nevirapine for the prevention of mother-to-child transmission of HIV.
Chalermchockcharoenkit A; Culnane M; Chotpitayasunondh T; Vanprapa N; Leelawiwat W; Mock PA; Asavapiriyanont S; Teeraratkul A; McConnell MS; McNicholl JM; Tappero JW
Clin Infect Dis; 2009 Jul; 49(2):299-305. PubMed ID: 19522656
[TBL] [Abstract][Full Text] [Related]
4. Zidovudine with nevirapine for the prevention of HIV mother-to-child transmission reduces nevirapine resistance in mothers from the Western Cape, South Africa.
van Zyl GU; Claassen M; Engelbrecht S; Laten JD; Cotton MF; Theron GB; Preiser W
J Med Virol; 2008 Jun; 80(6):942-6. PubMed ID: 18428139
[TBL] [Abstract][Full Text] [Related]
5. Characterization of nevirapine (NVP) resistance mutations and HIV type 1 subtype in women from Abidjan (Côte d'Ivoire) after NVP single-dose prophylaxis of HIV type 1 mother-to-child transmission.
Toni TD; Masquelier B; Lazaro E; Dore-Mbami M; Ba-Gomis FO; Téa-Diop Y; Kouakou K; Diby J; Sia E; Soppi S; Essien S; Schrive MH; Pinson P; Chenal H; Fleury HJ
AIDS Res Hum Retroviruses; 2005 Dec; 21(12):1031-4. PubMed ID: 16379606
[TBL] [Abstract][Full Text] [Related]
6. A radiolabeled oligonucleotide ligation assay demonstrates the high frequency of nevirapine resistance mutations in HIV type 1 quasispecies of NVP-treated and untreated mother-infant pairs from Uganda.
Troyer RM; Lalonde MS; Fraundorf E; Demers KR; Kyeyune F; Mugyenyi P; Syed A; Whalen CC; Bajunirwe F; Arts EJ
AIDS Res Hum Retroviruses; 2008 Feb; 24(2):235-50. PubMed ID: 18284323
[TBL] [Abstract][Full Text] [Related]
7. Characterization of HIV type 1 reverse transcriptase mutations in infants infected by mothers who received peripartum nevirapine prophylaxis in Jos, Nigeria.
Ojesina AI; Mullins C; Imade G; Samuels J; Sankalé JL; Pam S; Sagay S; Idoko J; Kanki PJ
AIDS Res Hum Retroviruses; 2007 Dec; 23(12):1587-92. PubMed ID: 18160018
[TBL] [Abstract][Full Text] [Related]
8. Surveillance of antiretroviral drug resistance mutations in untreated young children living in the Central African Republic.
Charpentier C; Gody JC; Tisserand P; Matta M; Péré H; Fournier J; Mbitikon O; Bélec L
Antivir Ther; 2011; 16(8):1347-50. PubMed ID: 22155917
[TBL] [Abstract][Full Text] [Related]
9. Clonal amplification and maternal-infant transmission of nevirapine-resistant HIV-1 variants in breast milk following single-dose nevirapine prophylaxis.
Permar SR; Salazar MG; Gao F; Cai F; Learn GH; Kalilani L; Hahn BH; Shaw GM; Salazar-Gonzalez JF
Retrovirology; 2013 Aug; 10():88. PubMed ID: 23941304
[TBL] [Abstract][Full Text] [Related]
10. Comparison of nevirapine (NVP) resistance in Ugandan women 7 days vs. 6-8 weeks after single-dose nvp prophylaxis: HIVNET 012.
Eshleman SH; Guay LA; Mwatha A; Cunningham SP; Brown ER; Musoke P; Mmiro F; Jackson JB
AIDS Res Hum Retroviruses; 2004 Jun; 20(6):595-9. PubMed ID: 15242535
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 drug resistance emergence among breastfeeding infants born to HIV-infected mothers during a single-arm trial of triple-antiretroviral prophylaxis for prevention of mother-to-child transmission: a secondary analysis.
Zeh C; Weidle PJ; Nafisa L; Lwamba HM; Okonji J; Anyango E; Bondo P; Masaba R; Fowler MG; Nkengasong JN; Thigpen MC; Thomas T
PLoS Med; 2011 Mar; 8(3):e1000430. PubMed ID: 21468304
[TBL] [Abstract][Full Text] [Related]
12. Antiretroviral therapy for prevention of mother-to-child HIV transmission : focus on single-dose nevirapine.
Giaquinto C; Rampon O; De Rossi A
Clin Drug Investig; 2006; 26(11):611-27. PubMed ID: 17163296
[TBL] [Abstract][Full Text] [Related]
13. Minority HIV-1 drug-resistant mutations and prevention of mother-to-child transmission: perspectives for resource-limited countries.
Samuel R; Paredes R; Parboosing R; Moodley P; Gordon M
AIDS Rev; 2014; 16(4):187-98. PubMed ID: 25300623
[TBL] [Abstract][Full Text] [Related]
14. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
[TBL] [Abstract][Full Text] [Related]
15. [Drug resistance of HIV-1 as a result of using nevirapine for chemoprophylaxis of vertical viral transmission from HIV-infected mother to infant].
Kazennova EV
Vopr Virusol; 2009; 54(1):45-8. PubMed ID: 19253732
[TBL] [Abstract][Full Text] [Related]
16. Resistance detected by pyrosequencing following zidovudine monotherapy for prevention of HIV-1 mother-to-child-transmission.
Olson SC; Ngo-Giang-Huong N; Beck I; Deng W; Britto P; Shapiro DE; Bumgarner RE; Mullins JI; Van Dyke RB; Jourdain G; Frenkel LM
AIDS; 2015 Jul; 29(12):1467-71. PubMed ID: 26244386
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 drug resistance and mother-to-child transmission.
Morris L; Pillay C; Gray G; McIntyre J
SADJ; 2001 Dec; 56(12):614-6. PubMed ID: 11887450
[TBL] [Abstract][Full Text] [Related]
18. Effective program against mother-to-child transmission of HIV at Saint Camille Medical Centre in Burkina Faso.
Simpore J; Pietra V; Pignatelli S; Karou D; Nadembega WM; Ilboudo D; Ceccherini-Silberstein F; Ghilat-Avoid-Belem WN; Bellocchi MC; Saleri N; Sanou MJ; Ouedraogo CM; Nikiema JB; Colizzi V; Perno CP; Castelli F; Musumeci S
J Med Virol; 2007 Jul; 79(7):873-9. PubMed ID: 17516517
[TBL] [Abstract][Full Text] [Related]
19. Genetic Analyses of HIV-1 Strains Transmitted from Mother to Child in Northern Vietnam.
Phan CT; Pham HV; Bi X; Ishizaki A; Saina M; Phung CD; Khu DT; Ichimura H
AIDS Res Hum Retroviruses; 2015 Aug; 31(8):797-805. PubMed ID: 25826000
[TBL] [Abstract][Full Text] [Related]
20. Genetic linkage of nevirapine resistance mutations in HIV type 1 seven days after single-dose nevirapine.
Jones D; Parkin N; Hudelson SE; Guay LA; Musoke P; Mmiro F; Jackson JB; Eshleman SH
AIDS Res Hum Retroviruses; 2005 Apr; 21(4):319-24. PubMed ID: 15943576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
